CORONA Remedies Limited (NSE:CORONA)

India flag India · Delayed Price · Currency is INR
1,685.20
-1.10 (-0.07%)
At close: Apr 28, 2026
14.64%
Market Cap 103.07B
Revenue (ttm) 13.44B
Net Income (ttm) 1.71B
Shares Out 61.16M
EPS (ttm) 28.02
PE Ratio 60.14
Forward PE 44.39
Dividend n/a
Ex-Dividend Date n/a
Volume 37,213
Average Volume 32,533
Open 1,686.30
Previous Close 1,686.30
Day's Range 1,675.50 - 1,743.80
52-Week Range 1,336.60 - 1,724.00
Beta n/a
RSI 61.39
Earnings Date May 21, 2026

About CORONA Remedies

CORONA Remedies Limited, a pharmaceutical formulation company, develops, manufactures, and markets pharmaceutical products. It provides products in women’s healthcare, cardio-diabeto, pain management, urology, thyroid management, respiratory, gastroenterology, and other therapeutic areas. The company was incorporated in 2004 and is based in Ahmedabad, India. [Read more]

Industry Pharmaceutical Preparations
Founded 2004
Employees 4,500
Stock Exchange National Stock Exchange of India
Ticker Symbol CORONA
Full Company Profile

Financial Performance

In fiscal year 2025, CORONA Remedies's revenue was 11.96 billion, an increase of 17.93% compared to the previous year's 10.14 billion. Earnings were 1.49 billion, an increase of 65.11%.

Financial Statements

News

There is no news available yet.